A cancer sensitizer comprising glucosamine, glucosamine derivatives or salts thereof

Details for Australian Patent Application No. 2006344575 (hide)

International Classifications

Event Publications

26 March 2009 Section 223 Application Allowed

National Cancer Center The time in which to enter the National Phase has been extended to 16 Mar 2009. Address for service in Australia - Wrays Ground Floor 56 Ord Street West Perth WA 6005 Extensions of Time, Section 223 2007

9 April 2009 PCT application entered the National Phase

PCT publication WO2007/145405 Priority application(s): WO2007/145405

9 June 2011 Application Accepted

Published as AU-B-2006344575

6 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.